Text and Data Mining valid from 2017-09-14
Received: 16 May 2017
Accepted: 16 June 2017
First Online: 14 September 2017
: D.B.G. is a founder of and holds equity in Pairnomix and Praxis, serves as a consultant to AstraZeneca, and has research supported by Janssen, Gilead, Biogen, AstraZeneca, and UCB. The other authors declare no conflict of interest.